Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular CarcinomaHaijing Deng, Ming Zhao, Anna Kan et al.|Liver Cancer|2020Cited by 179
Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trialZhiCheng Lai, Ming Shi, Wei Wei et al.|European Journal of Cancer|2022Cited by 154
NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinomaXiao-Ping Zhong, Rong Guo, Anna Kan et al.|Cell Death and Disease|2019Cited by 49
Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablationLianghe Lu, Rong Guo, Jie Mei et al.|Cancer Medicine|2020Cited by 45
Platelet-albumin-bilirubin grade: Risk stratification of liver failure, prognosis after resection for hepatocellular carcinomaLiang-He Lu, Rong Guo, Yong‐Fa Zhang et al.|Digestive and Liver Disease|2019Cited by 40